Metformin Use in Chronic Kidney Disease: The CKD-Met Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-03-31

Study Completion Date

2020-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Metformin is the most widely prescribed oral treatment for diabetes, and the only one that showed a survival benefit.

Yet, there is no consensus on the optimal dose and withdrawal of metformin in chronic kidney disease (CKD) patients.

The aim of the study is to describe the use and side-effects of metformin in CKD patients in routine practice.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Comparative Effectiveness of Metformin for Type 2 Diabetes With Chronic Kidney Disease

NCT03921242

Diabetes Mellitus, Type 2 Renal Insufficiency, Chronic

COMPLETED

Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease

NCT02656017

Polycystic Kidney, Autosomal Dominant

COMPLETED PHASE2

Feasibility Study of Metformin Therapy in ADPKD

NCT02903511

Polycystic Kidney, Autosomal Dominant

COMPLETED PHASE2

Clinical Study to Investigate the Pharmacokinetics and Pharmacodynamics of Metformin in the Elderly

NCT02125305

Healthy Elderly

COMPLETED PHASE1

Investigatory Study of Metformin's Pharmacokinetics, Pharmacodynamics and Drug Drug Interactions Classifying the Group by MATE1 Genotype in Healthy Volunteers

NCT01274130

Healthy Adult

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type 2 Diabetes Chronic Kidney Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

6 groups, for each CKD stage (1, 2, 3a, 3b, 4, 5)

All patients with type 2 diabetes seen for the first time by a nephrologist.

modalities of metformin prescription

Intervention Type OTHER

Metformin prescription or not, in each CKD stage

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

modalities of metformin prescription

Metformin prescription or not, in each CKD stage

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years old or more
* Type 2 diabetes
* Seen by a nephrologist (consultation or hospitalization) between March 2014 and March 2020 in the Department of Nephrology, Lyon Sud university hospital, France